TrialBMC cancer2016

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT).

Arndt Vogel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.